Skip to main content

Table 2 Patients characteristics at liver biopsy. Values are expressed as Mean ± SD

From: Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability

Parameter

Group A n = 31

(Peg-IFNα + RBV + placebo)

Group B n = 31

(Peg-IFNα + RBV + Silybin, Vit E, phospholipids)

p-value

Mean age (years)

45.8 ± 3.9

47.2 ± 3.7

N.S.

HCV exposure time (years)

5.87 ± 4.9

5.96 ± 4.2

N.S

BMI (kg/m2)

27.8 ± 3.1

27.4 ± 3.6

N.S.

Plasma glucose (mmol/l) (normal 3.9–6.4)

5.6 ± 0.78

5.9 ± 0.70

N.S.

AST (IU/l) (normal 15–50)

173.2 ± 37.8

178.4 ± 37.4

N.S.

ALT (IU/l) (normal 15–50)

187.2 ± 37.2

184.1 ± 38.2

N.S.

Viremia (106 IU/ml)

5.21 ± 2.24

5.20 ± 2.44

N.S.

HAI

10.7 ± 3.2

10.9 ± 3.4

N.S.